ICIC & ISAAR 2019 (4th International Interscience Conference on Infection and Chemotherapy & 12th International Symposium on Antimicrobial Agents and Resistance)

ICIC & ISAAR 2019 (4th International Interscience Conference on Infection and Chemotherapy & 12th International Symposium on Antimicrobial Agents and Resistance) is organized by Asia Pacific Foundation for Infectious Diseases (APFID), The Korean Society of Infectious Diseases (KSID) and will be held from Sep 26 - 28, 2019 at Hwabaek International Convention Center (HICO), Gyeongju, Kyongsangbuk, South Korea..

Theme: “Toward Ending Global Epidemic of Infectious Diseases and Antimicrobial Resistance”

Conference Description:
APFID (Asia Pacific Foundation for Infectious Diseases), Asia’s first foundation on infectious diseases headquartered in Korea, and KSID (the Korean Society for Infectious Diseases), which has been leading the domestic epidemiology research and treatment through its 55-year history and tradition, are to hold the joint meeting of ICIC & ISAAR 2019.

ICIC (The 4th International Interscience Conference on Infection and Chemotherapy) hosted by KSID to strengthen multidisciplinary collaboration on infectious diseases both domestically and globally and co-organized by 11 national relevant associations and societies has evolved into one of the globally-renowned conferences attended by domestic and global infectious disease experts and researchers since 2011.

ISAAR aims to contribute to the pivotal exchange of state-of-the-art information and data on infectious diseases and antimicrobial resistance in the world. Epidemiology, mechanism of resistance, pathogenesis, clinical impact, development of new antimicrobial agents and vaccines, and guidelines of treatment and prevention are the major issues of ISAAR. This cutting-edge information can foster global solutions to the problem of infectious diseases and antimicrobial resistance. ISAAR is a very special global-scale meeting with strong emphasis on antimicrobial resistance, antimicrobial treatment, new antimicrobial agents and vaccines, and the future strategies against infectious disease threats.

It will be characterized by the more informative, stimulating, and exciting program. 8 plenary keynote lectures, 15 main scientific sessions, 9 industry-organized Satellite Symposia, poster & oral presentations, and large industrial exhibition will provide more than 2,000 participants from > 50 countries and sponsors with satisfaction and unforgettable memories. More than 50 distinguished speakers will be invited from all continents.

Additional details will be posted as soon as they are available.